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(A) Coomassie stain of kinase domain BRAF protein purified over a nickel column to >95% purity. Initial rates of MEK phosphorylation were measured at different concentrations of ATP.
(B) BRAF and CRAF were treated with ATP to promote auto-inhibition. Auto-phosphorylated (pBRAF and pCRAF) and control RAF enzymes were then treated with the indicated concentrations of Cmpd A for 1 hour prior to adding 20 nM kinase dead MEK1 and 10 µM ATP substrates. MEK1 phosphorylation was then measured, and is shown as a % of the DMSO treated enzyme. Mass Spectrometry. To identify RAF autophosphorylation sites that mediate RAF inhibition, BRAF or CRAF kinase domains were incubated in 1mM ATP. Phosphorylated BRAF and CRAF kinase domains were run on SDS gel followed by trypsin digestion. Resulting peptides were analyzed using a LTQ-orbitrap mass spectrometer (Thermo Fisher Scientific Inc., San Jose, CA) hyphenated with Agilent 1100 HPLC (Agilent, Andover, MA). Identification of the peptides was performed by searching the MS/MS fragmentation data against BRAF and CRAF sequence using MASCOT search software (Matrix Science).
